stockrow
Friday 6 November 2026
Export QUCY’s income statement to Excel — free account
Quantum Cyber N.V
QUCY Healthcare Diagnostics & Research
Quantum Cyber N.V’s revenue for fiscal 2025 (year ended December 2025) was $537,100.00, down 39.9% from fiscal 2024.
- EPS
- +96.0%
- Free cash flow
- +26.7%
Quarter to June 2026, against a year earlier
0.70
0.00
0.00%
Follow QUCY
Alert me
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.00% | 0.00% | (552.83%) | (325.19%) | |
| 0.00% | 0.00% | (186.52%) | (165.20%) | ||
ROIC |
0.00% | 0.00% | (7,835.86%) | (193.99%) | |
Return on Tangible Assets |
0.00% | 0.00% | (620.52%) | (190.12%) | |
Average Days of Receivables |
0.00 | — | — | — | |
Free Cash Flow per Share |
0.00 | — | (1.60) | (0.93) | |
Free Cash Flow |
(20.45) | — | (18.89) | (16.60) | |
Capital Expenditures |
(1.13) | — | (1.52) | (0.19) | |
| Other line items | |||||
Cash ROIC |
(339.94%) | 0.00% | (208.99%) | (49.21%) | |
Accounts Receivable Turnover |
0.00 | — | — | — | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | — | — | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | — | — | — | |
Tax Rate |
— | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Operating CF/Net income |
0.00 | — | 0.81 | 0.62 | |
Depreciation/Fixed assets |
0.87 | — | 0.00 | 4.06 | |
Capex/Depreciation |
(0.94) | — | (1.44) | (0.34) | |
Revenue per Share |
— | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | — | (1.47) | (0.92) | |
Capex per Share |
0.00 | — | (0.13) | (0.01) | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 25 Oct 2026